Xin-Yu Ke
Overview
Explore the profile of Xin-Yu Ke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
168
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ke X, Zou M, Xu C
Life Metab
. 2025 Jan;
1(3):211-223.
PMID: 39872079
As an essential part of adaptive immunity, T cells coordinate the immune responses against pathogens and cancer cells. Lipid metabolism has emerged as a key regulator for the activation, differentiation,...
2.
Ge P, Liu S, Xu S, Zhang J, Lai Y, Fu R, et al.
Front Public Health
. 2022 May;
10:845032.
PMID: 35493366
Objective: To explore the influence of parents on the medication adherence of their children. Study Design: A cross-sectional online investigation. Methods: A questionnaire with 41 questions was designed based on...
3.
Shen H, An O, Ren X, Song Y, Tang S, Ke X, et al.
Nat Commun
. 2022 Mar;
13(1):1508.
PMID: 35314703
Circular RNAs (circRNAs) are produced by head-to-tail back-splicing which is mainly facilitated by base-pairing of reverse complementary matches (RCMs) in circRNA flanking introns. Adenosine deaminases acting on RNA (ADARs) are...
4.
Xu L, Chen Y, Huang Y, Sandanaraj E, Yu J, Lin R, et al.
Sci Adv
. 2021 May;
7(18).
PMID: 33931443
Molecular profiling of the most aggressive brain tumor glioblastoma (GBM) on the basis of gene expression, DNA methylation, and genomic variations advances both cancer research and clinical diagnosis. The enhancer...
5.
Chen L, Xu T, Qiu Y, Liu N, Ke X, Fang L, et al.
J Biochem Mol Toxicol
. 2021 Mar;
35(5):e22737.
PMID: 33751715
Homocysteine (Hcy) is a sulfur-containing amino acid that originated in methionine metabolism and the elevated level of Hcy in plasma is considered to be an independent risk factor for cardiovascular...
6.
Ke X, Chen Y, Tham V, Lin R, Dakle P, Nacro K, et al.
Oncogene
. 2021 Feb;
40(10):1851-1867.
PMID: 33564073
Soft tissue sarcoma (STS) is a heterogeneous disease that arises from connective tissues. Clinical outcome of patients with advanced tumors especially de-differentiated liposarcoma and uterine leiomyosarcoma remains unsatisfactory, despite intensive...
7.
Chen Y, Xu L, Mayakonda A, Huang M, Kanojia D, Tan T, et al.
Nat Commun
. 2019 Mar;
10(1):1353.
PMID: 30903020
Liposarcomas (LPSs) are a group of malignant mesenchymal tumors showing adipocytic differentiation. Here, to gain insight into the enhancer dysregulation and transcriptional addiction in this disease, we chart super-enhancer structures...
8.
Xu L, Chen Y, Mayakonda A, Koh L, Chong Y, Buckley D, et al.
Proc Natl Acad Sci U S A
. 2018 May;
115(22):E5086-E5095.
PMID: 29764999
Competitive BET bromodomain inhibitors (BBIs) targeting BET proteins (BRD2, BRD3, BRD4, and BRDT) show promising preclinical activities against brain cancers. However, the BET protein-dependent glioblastoma (GBM)-promoting transcriptional network remains elusive....